* CELLIAL TECHNOLOGIES *
2001 - North-Picardie
Lens
www.cellial.com Contract, Research
Key words: CNS research optimization, In vitro cell culture, Blood-Brain Barrier
Mission: accelerate CNS profiling and identify qualified leads candidates and eliminates the botleneck of drug transport accross Blood-Brain Barrier from clients' discovery process
Clients: Pharmaceutical industry, Biotechs, Academic labs
contact@cellial.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.: Wendzinski (Yves) [Eng. ISEN]
Sc.Dir.: Berezowski (Vincent) [Ph.D.]
Fin.Dir.:
BusDev:
Financers: Finorpa, Nord Innovation, Innovam
Communication: no website news update since 2005 in October 2008 | Turnover (M€) : 0.4 (2004)
Total funding (M€) : 1.0
Last funding (M€) : 1.0
Focus : Multiple
Position : Subcontractor
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2002 .10 | Nomination : Yves Wendzinski as CEO (also Chairman), replacing Michel Major | ORGN | [1 year] |
| 2002 .11 | 1st round-financing : 1.0 M€, by Finorpa, Nord Innovation, Innovam | RFINA | [1 year] |
| 2001 .01 | Company founded by Prof. Romeo Cecchelli (Institut Pasteur Lille), within Eurasanté Bio-incubator | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
